Heterogeneous<i>HER2</i>Gene Amplification
Alastair I. Bartlett(Edinburgh Cancer Research), John M.S. Bartlett(Edinburgh Cancer Research), Daniel Rea(University Hospitals Birmingham NHS Foundation Trust), Christos Markopoulos(Beth Israel Deaconess Medical Center), Jane Starcyznski(Heartlands Hospital), Fiona Campbell(University of Birmingham), Caroline Seynaeve(Radboud University Nijmegen), Alex MacLellan(Edinburgh Cancer Research), Annette Hasenburg(National and Kapodistrian University of Athens), Tammy Robson(National and Kapodistrian University of Athens), Cornelis J.�H. van de Velde(Leiden University Medical Center)
Cited by 106
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
|Surgery|2009|1.5k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k